drug marketing

Are Scare Tactics Being Used to Avoid Biosimilar Competition?
Are Scare Tactics Being Used to Avoid Biosimilar Competition?
BioSpace
biosimilars
competition
drug marketing
Flag link:
Pharma DTC spending outpaces rest of medical marketing, JAMA study finds
Pharma DTC spending outpaces rest of medical marketing, JAMA study finds
BioPharma Dive
DTC advertising
drug marketing
Flag link:
Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows
Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows
Fierce Pharma
FDA
drug reps
physicians
Eisai
Fycompa
drug marketing
Flag link:
Insight: How Novartis built a ‘money-filled moat’ to market Kymriah
Insight: How Novartis built a ‘money-filled moat’ to market Kymriah
Biopharma Reporter
Novartis
Kymriah
competition
drug marketing
CAR-T
Flag link:
Adempas maker Bayer connects hypertension patients with new mentoring group
Adempas maker Bayer connects hypertension patients with new mentoring group
Fierce Pharma
Bayer
patients
drug marketing
hypertension
Adempas
Flag link:
Tough time targeting women, pharma? Think time-crunched and family-first: study
Tough time targeting women, pharma? Think time-crunched and family-first: study
Fierce Pharma
drug marketing
women
Flag link:
FDA Explains Physician Survey on Drug Marketing
FDA Explains Physician Survey on Drug Marketing
RAPS.org
FDA
drug marketing
physicians
drug reps
Flag link:
FDA's promo police put pharma marketing to the test with 6 new research studies
FDA's promo police put pharma marketing to the test with 6 new research studies
Fierce Pharma
FDA
OPDP
drug marketing
drug ads
Flag link:
Johnson & Johnson’s stay-out-of-jail marketing for schizophrenia blockbuster Invega Sustenna raises eyebrows
Johnson & Johnson’s stay-out-of-jail marketing for schizophrenia blockbuster Invega Sustenna raises eyebrows
Fierce Pharma
JNJ
drug marketing
schizophrenia
Invega Sustenna
Flag link:
Beat you to it, Purdue. Other opioid makers already ditched promotions
Beat you to it, Purdue. Other opioid makers already ditched promotions
Fierce Pharma
Purdue
opioids
opioid crisis
drug marketing
Teva Pharmaceutical
Janssen
Allergan
Endo International
Flag link:
As CAR-Ts go from candidates to brands, what's the marketing strategy?
As CAR-Ts go from candidates to brands, what's the marketing strategy?
Medical Marketing and Media
CAR-T
drug marketing
JCAR017
Juno Therapeutics
Celgene
bb2121
Bluebird Bio
apalutamide
Janssen
Flag link:
Expect augmented reality to come up big for pharma marketers: expert
Expect augmented reality to come up big for pharma marketers: expert
Fierce Pharma
augmented reality
drug marketing
Flag link:
End of an era: Purdue to stop marketing opioids to doctors
End of an era: Purdue to stop marketing opioids to doctors
Stat
Purdue Pharma
drug marketing
oxycontin
opioids
opioid crisis
Flag link:
Takeda teams with Cedars Sinai on tech tool to personalize IBD treatment choices
Takeda teams with Cedars Sinai on tech tool to personalize IBD treatment choices
Fierce Pharma
drug marketing
Takeda
Cedars Sinai
IBD
mobile apps
Flag link:
GSK, Bayer top global ranking for online messaging
GSK, Bayer top global ranking for online messaging
Fierce Pharma
GSK
Bayer
online messaging
pharma websites
drug marketing
Flag link:
Hyperpersonalization, or super-targeted marketing, is a growing pharma opportunity, agency says
Hyperpersonalization, or super-targeted marketing, is a growing pharma opportunity, agency says
Fierce Pharma
drug marketing
pharma marketing
hyperpersonalization
Flag link:
Pharma's selfie game is strong, and it could get stronger next year
Pharma's selfie game is strong, and it could get stronger next year
Fierce Pharma
drug marketing
social media
Flag link:
4 Ways To Market CAR-T Therapies
4 Ways To Market CAR-T Therapies
Medical Marketing and Media
drug marketing
CAR-T
Flag link:
Insys ignored warnings about marketing powerful opioid Subsys
Insys ignored warnings about marketing powerful opioid Subsys
Stat
Insys
opioids
Subsys
drug marketing
Flag link:
Nordisk settles DOJ’s Victoza marketing suit for $59m
Nordisk settles DOJ’s Victoza marketing suit for $59m
Drug Delivery Business News
Novo Nordisk
DOJ
Victoza
drug marketing
Flag link:

Pages